NCT02408536招募中不适用
Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
National Cancer Institute, Naples1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- risk of recurrence in patients with low-grade serous ovarian carcinoma
研究概览
简要总结
The purpose of this study is to retrospectively evaluate treatments and outcomes of patients with low grade serous ovarian carcinomas in Italy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Diagnosis low-grade serous ovarian carcinoma
- •OR invasive recurrence after surgical resection of borderline serous ovarian carcinoma
- •Availability of archival tumor specimen (paraffin embedded block) for central analysis and evaluation for mutations
- •Age > 18 years
- •Signed informed consent
排除标准
- •High-grade serous, mucinous, endometrioid, or any other non-low-grade serous ovarian carcinoma
- •Unavailability of archival tumor specimen
结局指标
主要结局
risk of recurrence in patients with low-grade serous ovarian carcinoma
时间窗: two years
number of patients with objective tumor response after receiving chemotherapy
时间窗: 6 months
number of patients with objective tumor response after receiving hormone therapy
时间窗: 6 months
overall survival
时间窗: 5 years
number of patients with objective tumor response after receiving combination hormonal and chemotherapy
时间窗: 6 months
progression free survival
时间窗: 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Adalimumab Biosimilar in Clinical PracticePsoriasisNCT04808739Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau604
撤回
不适用
Study in Adult and Pediatric Patients With HSCT-TMAStem Cell Transplant ComplicationsThrombotic MicroangiopathiesNCT04970004Alexion Pharmaceuticals, Inc.
招募中
不适用
A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)Severe Hemophilia A Without InhibitorNCT05981274Tri-Service General Hospital45
已完成
不适用
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in BelgiumCarcinoma, Non-Small-Cell LungNCT03761901AstraZeneca141
Unknown
不适用
The Effects of Dapagliflozin in Normal Clinical Practice in T2DType 2 DiabetesNCT05418946University of Milan1,400